Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
PETROCHINA
00857
CN Stock MarketDetailed Quotes
CSPC Hunan Jingfeng Pharmaceutical (000908)
- 7.22
- +0.17+2.41%
Market Closed May 8 15:00 CST
12.70BMarket Cap-195.14P/E (TTM)
7.32High6.95Low209.63KlotVolume7.02Open7.05Prev Close148.70MTurnover2.38%Turnover RatioLossP/E (Static)1.76BShares8.5752wk High6.09P/B6.35BFloat Cap3.1652wk Low7.40Limit Up879.77MShs Float19.51Historical High6.70Limit Down5.25%Range %0.49Historical Low--Dividend TTM7.09Avg Price98.49KlotAsk--Div Yield TTM100Lot Size106.03KlotBid
CSPC Hunan Jingfeng Pharmaceutical (000908) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 8.05%83.19M | -14.97%360.53M | -25.67%248.38M | -31.00%163.06M | -44.27%76.99M | -43.43%424.03M | -42.94%334.18M | -38.59%236.34M | -31.73%138.15M | -22.12%749.53M |
| Refunds of taxes and levies | ---- | ---- | --1.16K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | -56.89%9.59M | 54.42%54.06M | 37.78%43.08M | -53.42%6.88M | 132.09%22.23M | -40.51%35.01M | -43.23%31.27M | -51.19%14.77M | 73.03%9.58M | -19.60%58.85M |
| Cash inflows from operating activities | -6.50%92.77M | -9.68%414.6M | -20.24%291.46M | -32.32%169.94M | -32.83%99.22M | -43.21%459.04M | -42.96%365.44M | -39.51%251.11M | -28.94%147.73M | -22.22%808.38M |
| Goods services cash paid | -5.75%25.88M | -30.47%109.86M | -29.62%80.69M | -32.29%54.32M | -49.48%27.46M | 27.56%158M | 47.34%114.66M | 56.48%80.23M | 132.56%54.36M | -14.42%123.87M |
| Staff behalf paid | 3.02%21.37M | -14.53%74.94M | -18.60%52.73M | -19.49%36.27M | -12.74%20.75M | -33.39%87.68M | -40.45%64.78M | -34.00%45.06M | -34.45%23.77M | -17.34%131.64M |
| All taxes paid | 11.10%16.98M | 11.16%46.36M | 70.44%34.64M | 61.14%24.34M | 71.48%15.28M | -55.30%41.71M | -73.33%20.32M | -74.75%15.11M | -71.11%8.91M | 24.27%93.31M |
| Cash paid relating to other operating activities | 312.19%100.07M | -29.96%124.11M | -34.75%93.16M | -39.88%56.68M | -53.34%24.28M | -58.26%177.2M | -57.85%142.77M | -56.87%94.28M | -49.87%52.03M | -20.93%424.51M |
| Cash outflows from operating activities | 87.20%164.31M | -23.53%355.27M | -23.74%261.22M | -26.87%171.62M | -36.89%87.77M | -39.92%464.59M | -43.05%342.54M | -41.03%234.68M | -28.41%139.08M | -15.58%773.32M |
| Net cash flows from operating activities | -724.58%-71.54M | 1,168.67%59.32M | 32.02%30.24M | -110.18%-1.67M | 32.49%11.45M | -115.83%-5.55M | -41.61%22.9M | -4.02%16.43M | -36.55%8.64M | -71.55%35.06M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | --119.68M | --705.88K | --705.88K | --705.88K | --0 | ---- | ---- | ---- | -90.51%5.06M |
| Cash received from returns on investments | ---- | ---- | --93.87M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -99.09%600.38K | 885.68%1.75M | 748.48%1.51M | 619.50%1.24M | 776.60%65.87M | -95.46%177.8K | -94.09%177.9K | -84.79%171.8K | -93.65%7.51M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | -78.08%142.5K | ---- | ---- | ---- | --650.1K | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | --735.76K | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | ---- | 83.72%121.02M | 11,552.62%96.47M | 1,145.26%2.22M | 1,030.38%1.94M | 423.91%65.87M | -79.05%827.9K | -94.16%177.9K | -85.04%171.8K | -94.66%12.57M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 6,280.57%3.02M | 230.62%4.57M | 8.18%1.28M | -33.97%554.2K | -91.93%47.4K | -86.74%1.38M | -83.35%1.19M | -86.66%839.29K | -88.71%587.7K | -22.90%10.42M |
| Cash paid to acquire investments | ---- | --31.46M | 125,743.42%31.46M | --31.46M | ---- | ---- | --25K | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | --308.76K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.52M |
| Cash outflows from investing activities | 6,280.57%3.02M | 2,530.87%36.34M | 2,602.63%32.74M | 3,714.55%32.02M | -91.93%47.4K | -93.70%1.38M | -92.39%1.21M | -93.28%839.29K | -90.83%587.7K | 62.33%21.94M |
| Net cash flows from investing activities | -259.63%-3.02M | 31.31%84.68M | 16,709.58%63.73M | -4,405.63%-29.8M | 555.54%1.89M | 788.49%64.49M | 96.80%-383.68K | 93.00%-661.39K | 92.09%-415.9K | -104.22%-9.37M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --1.93B | --0 | ---- | ---- | ---- | -84.47%172.7K | --172.7K | --172.7K | ---- | 65.49%1.11M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | -84.47%172.7K | ---- | ---- | ---- | --1.11M |
| Cash from borrowing | ---- | --0 | ---- | ---- | ---- | -89.68%16.3M | -87.87%19.1M | -95.59%6.5M | ---- | -8.87%158M |
| Cash received relating to other financing activities | ---- | --0 | --20M | --20M | ---- | --10.34M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | --1.93B | --0 | 3.77%20M | 199.73%20M | ---- | -83.15%26.81M | -87.81%19.27M | -95.49%6.67M | --0 | -13.97%159.11M |
| Borrowing repayment | 1,151.17%253.11M | 574.43%143.28M | 586.75%143.28M | 108.54%21.58M | 1,249.42%20.23M | -87.77%21.25M | -88.50%20.86M | -93.69%10.35M | -98.95%1.5M | -61.76%173.71M |
| Dividend interest payment | 306.21%12.37M | -21.46%10.53M | 0.28%9.47M | -12.64%6.1M | -19.95%3.04M | -43.24%13.4M | -10.57%9.44M | -3.09%6.98M | -8.88%3.8M | -40.42%23.61M |
| Cash payments relating to other financing activities | --10.7M | 289.49%11.25M | ---- | --0 | ---- | -98.13%2.89M | 1,752.78%2.79M | 1,228.37%2M | ---- | 467.59%154.77M |
| Cash outflows from financing activities | 1,086.61%276.18M | 339.73%165.06M | 361.53%152.75M | 43.20%27.68M | 338.90%23.27M | -89.34%37.54M | -82.77%33.1M | -88.72%19.33M | -96.40%5.3M | -32.44%352.09M |
| Net cash flows from financing activities | 7,190.65%1.65B | -1,439.17%-165.06M | -860.26%-132.75M | 39.33%-7.68M | -338.90%-23.27M | 94.44%-10.72M | 59.33%-13.82M | 45.67%-12.66M | 42.43%-5.3M | 42.60%-192.98M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -1,420.99%-242.75K | -824.03%-243.36K | -344.55%-80.5K | -318.13%-46.34K | 98.33%-15.96K | 136.35%33.61K | 2,249.16%32.92K | 1,149.16%21.24K | -159,745.73%-957.81K | -161.16%-92.48K |
| Net increase in cash and cash equivalents | 15,946.40%1.58B | -144.15%-21.3M | -545.30%-38.87M | -1,350.06%-39.2M | -605.22%-9.94M | 128.83%48.25M | 229.39%8.73M | 120.08%3.14M | 332.42%1.97M | -1,964.78%-167.37M |
| Add:Begin period cash and cash equivalents | -36.24%37.48M | 457.84%58.79M | 457.84%58.79M | 353.74%58.79M | 353.74%58.79M | -94.08%10.54M | -94.19%10.54M | -92.72%12.96M | -92.86%12.96M | 5.31%177.91M |
| End period cash equivalent | 3,202.33%1.61B | -36.24%37.48M | 3.37%19.92M | 21.73%19.59M | 227.29%48.84M | 457.84%58.79M | -88.97%19.27M | -90.09%16.09M | -91.73%14.92M | -94.08%10.54M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Adverse Opinion |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm